Glioblastoma Clinical Trials in Siena
2 recruitingSiena, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma
NovoCure GmbH741 enrolled82 locationsNCT06556563
Recruiting
Phase 1Phase 2
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
Glioblastoma
Philogen S.p.A.142 enrolled15 locationsNCT04573192